Cargando…

M013 SUCCESSFUL FOUR-STEP GRADED-DOSE ADMINISTRATION TO THE PFIZER-MRNA SARS-COV-2 VACCINE IN A PATIENT WITH PREVIOUS ANAPHYLAXIS

Detalles Bibliográficos
Autores principales:	Morgenstern-Kaplan, D., Carrillo-Martin, I., Rivera, C., Parkulo, M., Gonzalez-Estrada, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566870/ http://dx.doi.org/10.1016/j.anai.2021.08.187

Ejemplares similares

Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG Allergy
por: McSweeney, Morgan D., et al.
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine-related risk of anaphylaxis
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech: Biphasic anaphylaxis: case report
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech: Biphasic anaphylaxis: case report
Publicado: (2021)

Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
Publicado: (2021)

COVID-19-Vaccine-Pfizer-BioNTech: Anaphylaxis: case report
Publicado: (2022)

COVID-19-vaccine-Pfizer-BioNTech: Anaphylaxis: 21 case reports
Publicado: (2021)

Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
por: Tuong, Linh-An C, et al.
Publicado: (2021)

REVISITING HYPERSENSITIVITY REACTIONS TO THE MRNA COVID-19 VACCINE: TOLERANCE AFTER PREVIOUS HISTORY OF ANAPHYLAXIS
por: AlOtaibi, I., et al.
Publicado: (2022)

Prolonged Anaphylaxis to Pfizer Coronavirus Disease 2019 Vaccine: A Case Report and Mechanism of Action
por: Frank, Ashleigh, et al.
Publicado: (2021)

COVID-19-Vaccine-Pfizer-BioNTech: Anaphylaxis to excipient polyethylene glycol: case report
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech/elasomeran: Anaphylaxis and skin reaction: 2 case reports
Publicado: (2022)

Delayed-onset anaphylaxis after first dose of Pfizer-BioNTech COVID-19 vaccine
por: Tay, Carol, et al.
Publicado: (2022)

Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report
por: Iguchi, Toyotaka, et al.
Publicado: (2021)

O013: Abstract withdrawn
Publicado: (2013)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
por: Lim, Xin Rong, et al.
Publicado: (2021)

Increasing anaphylaxis events in Western Australia identified using four linked administrative datasets()
por: Salter, Sandra M., et al.
Publicado: (2020)

Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization
por: AlOtaibi, Ibtihal, et al.
Publicado: (2023)

mRNA 1273: Anaphylaxis: case report
Publicado: (2021)

Status report of the HARP experiment, 2002-013
por: Dydak, Friedrich, et al.
Publicado: (2002)

P01-013 – Cochlear involvement in FMF
por: Ayaz, N Aktay, et al.
Publicado: (2013)

P03-013 - Symptomatic neuromuscular sarcoidosis
por: Mulazzani, M, et al.
Publicado: (2013)

AB013. Diagnosis and treatment of premature ejaculation
por: Gao, Bing, et al.
Publicado: (2017)

Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells
por: Terashita, Tomomi, et al.
Publicado: (2016)

Generation of KCL013 research grade human embryonic stem cell line carrying a mutation in the HTT gene
por: Jacquet, Laureen, et al.
Publicado: (2016)

The usability of testing skin reaction applying skin prick tests with Comirnaty (Pfizer, USA) vaccine in detecting the risk of developing post-vaccination immediate hypersensitivity response (anaphylaxis) after administration of this vaccine
por: Gulas, Ewelina, et al.
Publicado: (2023)

Analysis and Conceptual Design of the HLT Selection Software 013
por: Elsing, M
Publicado: (2002)

PW01-013 – Localization of alternative pyrin isoforms
por: Turanli, E Tahir, et al.
Publicado: (2013)

Ruminococcaceae_UCG-013 Promotes Obesity Resistance in Mice
por: Feng, Jinlian, et al.
Publicado: (2022)

A case of myopericarditis following administration of the Pfizer COVID-19 vaccine
por: Morton, Zoey, et al.
Publicado: (2022)

Safety and efficacy of graded dosing of Pfizer-BioNTech mRNA COVID-19 vaccine after an immediate hypersensitivity reaction to first dose
por: Regula, Prudhvi, et al.
Publicado: (2022)

M044 POLYETHYLENE GLYCOL ALLERGY TESTING AN ADOLESCENT WITH ANAPHYLAXIS TO PEG-ASPARAGINASE BEFORE ADMINISTERING PFIZER-BIONTECH COVID-19 VACCINE
por: Breidenbaugh, M.
Publicado: (2021)

The Timely Administration of Epinephrine and Related Factors in Children with Anaphylaxis
por: Cha, Lily Myung-Jin, et al.
Publicado: (2022)

Administration d’adrénaline en cas d’anaphylaxie
por: Morriello, Florence, et al.
Publicado: (2023)

IgE-Mediated Reaction to Levamisole: Evaluation of a Patient With Severe Anaphylaxis
por: Garzon-Siatoya, Wendy T, et al.
Publicado: (2021)

Triage Grading and Correct Diagnosis Are Critical for the Emergency Treatment of Anaphylaxis
por: Dondi, Arianna, et al.
Publicado: (2022)

Lichenoid cutaneous skin eruption and associated systemic inflammatory response following Pfizer‐BioNTech mRNA COVID‐19 vaccine administration
por: Onn, Pei‐Yee, et al.
Publicado: (2021)

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
por: Risma, Kimberly A., et al.
Publicado: (2021)

The conundrum of COVID-19 mRNA vaccine–induced anaphylaxis
por: Khalid, Muhammad Bilal, et al.
Publicado: (2022)

PW03-013 - Behçet's disease: genotype-phenotype correlations
por: Takeuchi, M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rorkn97aeu31t5r9g5sfot7g72